Document Detail


The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
MedLine Citation:
PMID:  8542164     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pretreatment with inhaled beta 2-agonists is often recommended for the prevention of exercise-induced bronchoconstriction. Regular treatment with inhaled beta 2-agonists has been associated with worsened baseline airway caliber and increased airway responsiveness. In this study, we have investigated the effects of regular inhaled albuterol on the severity of exercise-induced bronchoconstriction using a double-blind, placebo-controlled, randomized, crossover design. Ten subjects inhaled either albuterol or placebo (2 x 100 micrograms, four times per day) for 7 d. On the eighth and ninth days of treatment periods, subjects performed 5-min constant work rate cycle ergometry exercise challenges after inhaling 200 micrograms of placebo (eighth day) or albuterol (ninth day). Forced expired volume in 1 s (FEV1) was measured on arrival in the laboratory as well as before and for 1 h after exercise. One week of regular inhaled albuterol compared with placebo resulted in: (1) a lower baseline FEV1 (mean difference, 230 ml) (p = 0.02); (2) a lower minimum postexercises FEV1 without inhaled albuterol pretreatment (mean difference, 390 ml; range, -50 ml to 1,250 ml) (p = 0.01); (3) a lower minimum postexercise FEV1 with inhaled albuterol pretreatment (p < 0.01). The smallest degree of exercise-induced bronchoconstriction occurred after a week of regular placebo and pretreatment with inhaled albuterol immediately before exercise. Inhalation of albuterol four times daily for 1 wk worsens exercise-induced bronchoconstriction; however, it remains extremely effective when used immediately before exercise for preventing bronchoconstriction.
Authors:
M D Inman; P M O'Byrne
Related Documents :
8325154 - Influence of airway inflammatory changes on airway hyperresponsiveness in asthmatics.
10414394 - Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bron...
1247214 - Response of asthmatics to methacholine and suggestion.
336304 - Comparative bronchodilator responses to atropine and terbutaline in asthma and chronic ...
17301004 - Determination of the volume of sweat accumulated in a sweat-patch using sodium and pota...
10694114 - Blood volume: importance and adaptations to exercise training, environmental stresses, ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of respiratory and critical care medicine     Volume:  153     ISSN:  1073-449X     ISO Abbreviation:  Am. J. Respir. Crit. Care Med.     Publication Date:  1996 Jan 
Date Detail:
Created Date:  1996-02-13     Completed Date:  1996-02-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421642     Medline TA:  Am J Respir Crit Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  65-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Adrenergic beta-Agonists / administration & dosage*
Adult
Air
Albuterol / administration & dosage*
Analysis of Variance
Asthma / drug therapy*,  physiopathology
Bronchial Provocation Tests*
Bronchoconstriction*
Bronchodilator Agents / administration & dosage*
Cross-Over Studies
Double-Blind Method
Exercise Test
Female
Forced Expiratory Volume
Humans
Male
Placebos
Spirometry
Time Factors
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Bronchodilator Agents; 0/Placebos; 18559-94-9/Albuterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis.
Next Document:  Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.